118 related articles for article (PubMed ID: 15870882)
1. Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest.
Sato K; Kitajima Y; Kohya N; Miyoshi A; Koga Y; Miyazaki K
Int J Oncol; 2005 Jun; 26(6):1653-61. PubMed ID: 15870882
[TBL] [Abstract][Full Text] [Related]
2. The effect of o6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair gene (hMLH1) status on the sensitivity to alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea(ACNU) in gallbladder carcinoma cells.
Sato K; Kitajima Y; Koga Y; Miyazaki K
Anticancer Res; 2005; 25(6B):4021-8. PubMed ID: 16309194
[TBL] [Abstract][Full Text] [Related]
3. hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents.
Brown R; Hirst GL; Gallagher WM; McIlwrath AJ; Margison GP; van der Zee AG; Anthoney DA
Oncogene; 1997 Jul; 15(1):45-52. PubMed ID: 9233776
[TBL] [Abstract][Full Text] [Related]
4. Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models.
Middlemas DS; Stewart CF; Kirstein MN; Poquette C; Friedman HS; Houghton PJ; Brent TP
Clin Cancer Res; 2000 Mar; 6(3):998-1007. PubMed ID: 10741727
[TBL] [Abstract][Full Text] [Related]
5. Deficient expression of O(6)-methylguanine-DNA methyltransferase combined with mismatch-repair proteins hMLH1 and hMSH2 is related to poor prognosis in human biliary tract carcinoma.
Kohya N; Miyazaki K; Matsukura S; Yakushiji H; Kitajima Y; Kitahara K; Fukuhara M; Nakabeppu Y; Sekiguchi M
Ann Surg Oncol; 2002 May; 9(4):371-9. PubMed ID: 11986189
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer.
Liu L; Schwartz S; Davis BM; Gerson SL
Cancer Res; 2002 Jun; 62(11):3070-6. PubMed ID: 12036916
[TBL] [Abstract][Full Text] [Related]
7. Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity.
Hirose Y; Kreklau EL; Erickson LC; Berger MS; Pieper RO
J Neurosurg; 2003 Mar; 98(3):591-8. PubMed ID: 12650433
[TBL] [Abstract][Full Text] [Related]
8. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer.
Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M
Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399
[TBL] [Abstract][Full Text] [Related]
9. Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status.
Magrini R; Bhonde MR; Hanski ML; Notter M; Scherübl H; Boland CR; Zeitz M; Hanski C
Int J Cancer; 2002 Sep; 101(1):23-31. PubMed ID: 12209584
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea.
Sato K; Kitajima Y; Nakagawachi T; Soejima H; Miyoshi A; Koga Y; Miyazaki K
Oncol Rep; 2005 May; 13(5):899-906. PubMed ID: 15809756
[TBL] [Abstract][Full Text] [Related]
11. Roles of MGMT and MLH1 proteins in alkylation-induced apoptosis and mutagenesis.
Takagi Y; Takahashi M; Sanada M; Ito R; Yamaizumi M; Sekiguchi M
DNA Repair (Amst); 2003 Oct; 2(10):1135-46. PubMed ID: 13679151
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of DNA mismatch repair protein and O6-methylguanine-DNA methyltransferase in melanoma metastases in relation to clinical response to DTIC-based chemotherapy.
Ma S; Egyházi S; Ringborg U; Hansson J
Oncol Rep; 2002; 9(5):1015-9. PubMed ID: 12168066
[TBL] [Abstract][Full Text] [Related]
13. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon.
Oh K; Redston M; Odze RD
Hum Pathol; 2005 Jan; 36(1):101-11. PubMed ID: 15712188
[TBL] [Abstract][Full Text] [Related]
14. Combined loss of expression of O6-methylguanine-DNA methyltransferase and hMLH1 accelerates progression of hepatocellular carcinoma.
Matsukura S; Miyazaki K; Yakushiji H; Ogawa A; Chen Y; Sekiguchi M
J Surg Oncol; 2003 Mar; 82(3):194-200. PubMed ID: 12619064
[TBL] [Abstract][Full Text] [Related]
15. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice.
Kawate H; Itoh R; Sakumi K; Nakabeppu Y; Tsuzuki T; Ide F; Ishikawa T; Noda T; Nawata H; Sekiguchi M
Carcinogenesis; 2000 Feb; 21(2):301-5. PubMed ID: 10657972
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia.
Lenz G; Hutter G; Hiddemann W; Dreyling M
Ann Hematol; 2004 Oct; 83(10):628-33. PubMed ID: 15309527
[TBL] [Abstract][Full Text] [Related]
17. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
[TBL] [Abstract][Full Text] [Related]
18. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer.
Fox EJ; Leahy DT; Geraghty R; Mulcahy HE; Fennelly D; Hyland JM; O'Donoghue DP; Sheahan K
J Mol Diagn; 2006 Feb; 8(1):68-75. PubMed ID: 16436636
[TBL] [Abstract][Full Text] [Related]
19. CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection.
Matsukura S; Soejima H; Nakagawachi T; Yakushiji H; Ogawa A; Fukuhara M; Miyazaki K; Nakabeppu Y; Sekiguchi M; Mukai T
Br J Cancer; 2003 Feb; 88(4):521-9. PubMed ID: 12592365
[TBL] [Abstract][Full Text] [Related]
20. Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutations.
Sanada M; Takagi Y; Ito R; Sekiguchi M
DNA Repair (Amst); 2004 Apr; 3(4):413-20. PubMed ID: 15010317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
